1. Home
  2. AUB vs ORKA Comparison

AUB vs ORKA Comparison

Compare AUB & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic Union Bankshares Corporation

AUB

Atlantic Union Bankshares Corporation

HOLD

Current Price

$42.56

Market Cap

6.0B

Sector

Finance

ML Signal

HOLD

Logo Oruka Therapeutics Inc.

ORKA

Oruka Therapeutics Inc.

HOLD

Current Price

$112.14

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUB
ORKA
Founded
1902
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
7.1B
IPO Year
2005
1997

Fundamental Metrics

Financial Performance
Metric
AUB
ORKA
Price
$42.56
$112.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
12
Target Price
$41.88
$92.50
AVG Volume (30 Days)
941.1K
756.1K
Earning Date
04-21-2026
05-13-2026
Dividend Yield
3.98%
N/A
EPS Growth
N/A
N/A
EPS
1.95
N/A
Revenue
N/A
N/A
Revenue This Year
$29.16
N/A
Revenue Next Year
$4.59
N/A
P/E Ratio
$21.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.87
$14.08
52 Week High
$43.62
$111.37

Technical Indicators

Market Signals
Indicator
AUB
ORKA
Relative Strength Index (RSI) 55.06 75.19
Support Level $40.74 $82.34
Resistance Level $43.58 N/A
Average True Range (ATR) 0.71 5.61
MACD -0.07 1.07
Stochastic Oscillator 70.01 96.74

Price Performance

Historical Comparison
AUB
ORKA

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial and bank holding company based in the U.S. Through its community bank subsidiary and non-bank financial services affiliates, the company provides financial services, including banking, trust, and wealth management. It offers consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from the Wholesale Banking segment.

About ORKA Oruka Therapeutics Inc.

Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.

Share on Social Networks: